Format

Send to

Choose Destination
PLoS One. 2014 Dec 18;9(12):e115337. doi: 10.1371/journal.pone.0115337. eCollection 2014.

Identification of c-MYC SUMOylation by mass spectrometry.

Author information

1
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada.
2
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
3
Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.

Abstract

The c-MYC transcription factor is a master regulator of many cellular processes and deregulation of this oncogene has been linked to more than 50% of all cancers. This deregulation can take many forms, including altered post-translational regulation. Here, using immunoprecipitation combined with mass spectrometry, we identified a MYC SUMOylation site (K326). Abrogation of signaling through this residue by substitution with arginine (K326R) has no obvious effects on MYC half-life, intracellular localization, transcriptional targets, nor on the biological effects of MYC overexpression in two different cell systems assessed for soft agar colony formation, proliferation, and apoptosis. While we have definitively demonstrated that MYC SUMOylation can occur on K326, future work will be needed to elucidate the mechanisms and biological significance of MYC regulation by SUMOylation.

PMID:
25522242
PMCID:
PMC4270761
DOI:
10.1371/journal.pone.0115337
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center